Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.
Kajimoto
Katsuya
K
Department of Cardiology, Tokyo Women’s Medical University, Japan. kkajimoto@sensoji-h.or.jp
Imai
Taku
T
Minami
Yuichiro
Y
Kasanuki
Hiroshi
H
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D004206:Disopyramide / Q000627:therapeutic use*; D015150:Echocardiography, Doppler; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use; D011446:Prospective Studies; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D017725:Ventricular Pressure / Q000187:drug effects*; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; D008012:Lidocaine; D011433:Propranolol; C042288:pilsicainide; D014700:Verapamil; D004206:Disopyramide; C032151:cifenline